Co-Targeting of Bcl-2 and mTOR Pathway Triggers Synergistic Apoptosis in BH3 Mimetics Resistant Acute Lymphoblastic Leukemia
Author
McCubrey, James A.
Date
2015-09-16
Citation:
APA:
McCubrey, James A.. (September 2015).
Co-Targeting of Bcl-2 and mTOR Pathway Triggers Synergistic Apoptosis in BH3 Mimetics Resistant Acute Lymphoblastic Leukemia.
,
(),
-
. Retrieved from
http://hdl.handle.net/10342/9648
MLA:
McCubrey, James A..
"Co-Targeting of Bcl-2 and mTOR Pathway Triggers Synergistic Apoptosis in BH3 Mimetics Resistant Acute Lymphoblastic Leukemia". .
. (),
September 2015.
June 20, 2024.
http://hdl.handle.net/10342/9648.
Chicago:
McCubrey, James A.,
"Co-Targeting of Bcl-2 and mTOR Pathway Triggers Synergistic Apoptosis in BH3 Mimetics Resistant Acute Lymphoblastic Leukemia," , no.
(September 2015),
http://hdl.handle.net/10342/9648 (accessed
June 20, 2024).
AMA:
McCubrey, James A..
Co-Targeting of Bcl-2 and mTOR Pathway Triggers Synergistic Apoptosis in BH3 Mimetics Resistant Acute Lymphoblastic Leukemia. .
September 2015;
():
.
http://hdl.handle.net/10342/9648. Accessed
June 20, 2024.
Collections